Hemab: Funding, Investors & Team (Sep 2026)
Hemab is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders.
Hemab has raised $347M across 3 funding rounds on record, the most recent a Series C of $157M announced in Oct 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Hemab Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Hemab Funding Rounds
Hemab raised $55.0M in a Series A announced in Jul 2021.
1.6 years later, a Series B of $135M was announced in Feb 2023.
2.7 years later, a Series C of $157M was announced in Oct 2025.
Hemab Founders and Leadership Team
Contact details for the Hemab team: 2 of 2 have an email address on file.
Start 14-day free trial →Hemab Funding Compared to Other Biotechnology Startups
Hemab's latest round of $157M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hemab in Biotechnology and Copenhagen
Companies Similar to Hemab
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
Hemab Funding FAQs
What does Hemab do?
Hemab is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders.
How much funding has Hemab raised?
Hemab has raised $347M across 3 rounds on record. The most recent is a Series C of $157M announced in Oct 2025.
When did Hemab last raise funding?
Hemab's most recent funding round on record is a Series C of $157M, announced in Oct 2025.
Who founded Hemab?
FundedIQ lists Johan H Faber (Founder) at Hemab.
Who is the CEO of Hemab?
Benny Sorensen is listed as CEO at Hemab.
Where is Hemab headquartered?
Hemab is based in Copenhagen, Hovedstaden, Denmark.
How many employees does Hemab have?
Hemab is in the 1-10 employee band.
How does Hemab's funding compare to other Biotechnology startups?
Hemab's latest round of $157M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Hemab Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hemab is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.